Close Server: KOPWWW05 | Not logged in

Welcome to Health Care POV | sign in | join

October 2016 - Posts

ADVANCE Perspective: Respiratory Views

Data from Phase 1 Trial of Triplex Vaccine for Control of Cytomegalovirus Published in Blood
October 28, 2016 11:51 AM by ADVANCE for Respiratory Care & Sleep Medicine
By ADVANCE Perspectives Duarte, CA and New York, NY — City of Hope and Helocyte, Inc., a majority-owned subsidiary of Fortress Biotech, Inc. has announced that data from the Phase 1 trial of Helocyte’s Triplex vaccine were published online this month Read More...


About this Blog

Keep Me Updated